Recent Posts

Mealey's Emerging Securities Litigation Bulletin: Former Goldman Sachs Director Guilty of Insider Trading
Posted on 16 Jun 2012 by Mealeys

NEW YORK - Rajat Gupta, a former member of the boards of directors for The Goldman Sachs Group Inc. and the Procter & Gamble Co., today was found guilty by a federal jury of participating in an insider-trading scheme with former head of the Galleon... Read More

U.S. Supreme Court Declines Review of Insurer's Reinstated $92.9 Million Judgment
Posted on 26 Jun 2012 by Mealeys

WASHINGTON, D.C. - The U.S. Supreme Court yesterday denied an insurer's petition for a writ of certiorari challenging the Louisiana Supreme Court's finding that every member of a class of more than 18,000 insureds was entitled to recover the maximum... Read More

Mealey’s Financial Services Bulletin: Ponzi Mastermind Sentenced to 110 Years
Posted on 15 Jun 2012 by Mealeys

HOUSTON - The federal judge in Texas overseeing the criminal case of convicted Ponzi scheme mastermind R. Allen Stanford yesterday sentenced Stanford to 110 years in federal prison ( United States of America v. Robert Allen Stanford No. 09-342). (... Read More

Bank of America Agrees to Pay $375 Million to Settle Fraud Claims With Insurer
Posted on 18 Jul 2012 by Mealeys

NEW YORK - Bank of America Corp. and its Countrywide Home Loans Inc. affiliate will pay $375 million to a financial guarantee insurer to settle claims that Countrywide misrepresented the standards used in underwriting mortgage loans that served as the... Read More

Jury Awards HRT *** Cancer Plaintiff $5.1 Million Dollar Compensatory Verdict
Posted on 10 Sep 2012 by Mealeys

SALT LAKE CITY - A Utah federal jury on Sept. 7 awarded a hormone replacement therapy plaintiff $5.1 million in compensatory damages after finding that her *** cancer was caused by Premarin, Provera and Prempro and that manufacturer defendants Wyeth and... Read More

Mealey's Litigation Report: Employment Law Bulletin--Pharma Reps Not Owed Overtime
Posted on 18 Jun 2012 by Mealeys

WASHINGTON, D.C. - A pharmaceutical sales representative, or detailer, falls under the U.S. Department of Labor's (DOL) definition of an "outside salesman" and is not owed overtime compensation, a split U.S. Supreme Court ruled this morning... Read More